SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950135-08-001121
Filing Date
2008-02-21
Accepted
2008-02-21 09:53:19
Documents
6
Period of Report
2008-02-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 OXIGENE, INC. b68650oie8vk.htm 8-K 18874
2 EX-4.1 WARRANT FOR THE PURCHASE OF SHARES OF COMMON STOCK, DATED 2/19/2008 b68650oiexv4w1.htm EX-4.1 56471
3 EX-4.2 REGISTRATION RIGHTS AGREEMENT, DATED 2/19/2008 b68650oiexv4w2.htm EX-4.2 48897
4 EX-10.1 COMMON STOCK PURCHASE AGREEMENT, DATED 2/19/2008 b68650oiexv10w1.htm EX-10.1 192375
5 EX-99.1 PRESS RELEASE, DATED 2/20/2008 b68650oiexv99w1.htm EX-99.1 9771
6 GRAPHIC b68650oib6865000.gif GRAPHIC 4132
  Complete submission text file 0000950135-08-001121.txt   333702
Mailing Address
Business Address 321 ARSENAL STREET WATERTOWN MA 02472 6176737800
OXIGENE INC (Filer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21990 | Film No.: 08631710
SIC: 2836 Biological Products, (No Diagnostic Substances)